Saccharomyces cerevisiae CNCM I-3856
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Saccharomyces cerevisiae CNCM I-3856, covering 2017-06-20 to 2017-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction [NA]